ArticleJournal of clinical medicine2020

The Preliminary Results of Bortezomib Used as A Primary Treatment for An Early Acute Antibody-Mediated Rejection after Kidney Transplantation-A Single-Center Case Series.

Aureliusz Kolonko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.